Published in Curr Drug Saf on November 01, 2013
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. Diabetes Care (2016) 1.04
New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer. Br J Cancer (2015) 1.04
Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies. Sci Rep (2015) 0.98
Glycemic Index, Glycemic Load, and Lung Cancer Risk in Non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev (2016) 0.98
Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer. Cancer Epidemiol Biomarkers Prev (2016) 0.89
Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China. Sci Rep (2015) 0.85
Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence. Breast Cancer Res (2015) 0.85
Cardiovascular impact of drugs used in the treatment of diabetes. Ther Adv Chronic Dis (2014) 0.82
Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus. Acta Diabetol (2015) 0.78
All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine. PLoS One (2016) 0.77
Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer. Int J Cancer (2016) 0.77
The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus. PLoS One (2016) 0.77
Insulin glargine use and breast cancer risk: Associations with cumulative exposure. Acta Oncol (2016) 0.75
Diabetes, diabetes treatment, and mammographic density in Danish Diet, Cancer, and Health cohort. Cancer Causes Control (2016) 0.75
The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics. Int J Endocrinol (2016) 0.75
Diabetes and Breast Cancer Subtypes. PLoS One (2017) 0.75
Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals. Diabetologia (2016) 0.75
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study. Diabetes Ther (2016) 0.75
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia (2009) 10.95
Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med (2012) 10.09
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia (2009) 7.06
Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71
Diabetes and cancer. Endocr Relat Cancer (2009) 5.04
Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology (2009) 4.72
Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila) (2010) 4.36
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia (2009) 3.89
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia (2009) 3.82
Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes (2010) 3.77
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia (2012) 3.70
Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care (2010) 3.68
Does diabetes therapy influence the risk of cancer? Diabetologia (2009) 3.66
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology (2004) 3.57
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia (2011) 3.52
Insulin glargine and malignancy: an unwarranted alarm. Lancet (2009) 3.19
Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care (2012) 3.11
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus. Hepatology (2012) 2.63
Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol (2011) 2.60
Combined randomised controlled trial experience of malignancies in studies using insulin glargine. Diabetologia (2009) 2.34
Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia (2011) 2.15
Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab (2012) 2.06
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study. Diabetologia (2009) 2.04
Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy. Pancreas (2003) 1.98
Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia (2011) 1.89
Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care (2011) 1.83
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist (2012) 1.79
Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases. Diabetes Care (2012) 1.76
Epidemiological aspects of neoplasms in diabetes. Acta Diabetol (2010) 1.74
Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan. Clin Lung Cancer (2011) 1.70
Insulin analogues and cancer risk: cause for concern or cause célèbre? Int J Clin Pract (2010) 1.69
The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes. Prim Care Diabetes (2011) 1.69
Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia (2011) 1.62
Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care (2010) 1.60
Sulphonylureas and cancer: a case-control study. Acta Diabetol (2008) 1.56
The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res (2012) 1.53
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data. Diabetologia (2011) 1.53
Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients. Diabetes Care (2011) 1.52
Cancer risks in thiazolidinedione users compared to other anti-diabetic agents. Pharmacoepidemiol Drug Saf (2007) 1.50
Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev (2011) 1.44
No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis. Diabetologia (2009) 1.38
Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecol Oncol (2011) 1.38
Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology (2010) 1.31
Cancer risk associated with insulin glargine among adult type 2 diabetes patients--a nationwide cohort study. PLoS One (2011) 1.31
Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. J Gastroenterol Hepatol (2012) 1.29
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control (2010) 1.29
Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database. Diabetologia (2012) 1.28
Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis. Am J Gastroenterol (2012) 1.27
Diabetes therapy and cancer risk: causal effects and other plausible explanations. Diabetologia (2010) 1.21
Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 1.18
Metformin does not alter the risk of lung cancer: a case-control analysis. Lung Cancer (2012) 1.17
Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan. Ann Oncol (2011) 1.11
The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans. Cancer Epidemiol Biomarkers Prev (2009) 1.10
Insulin glargine use and short-term incidence of malignancies - a three-year population-based observation. Acta Oncol (2011) 1.09
The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project. Cancer Causes Control (2012) 1.05
Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J Gastroenterol (2010) 1.02
Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study. Metabolism (2011) 1.00
Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women. Cancer Causes Control (2012) 1.00
Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection. Liver Int (2009) 1.00
Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study. Int J Cancer (2012) 0.97
Insulin analogues and cancer risk: the emergence of second-generation studies. Diabetologia (2011) 0.95
Insulin glargine and cancer: another side to the story? Lancet (2009) 0.94
Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort. Diabetol Metab Syndr (2011) 0.94
Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age. J Gastroenterol (2012) 0.93
Type 2 diabetes mellitus, its treatment and risk for lymphoma. Eur J Cancer (2005) 0.92
Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study. Br J Dermatol (2005) 0.92
Gallstones, a cholecystectomy, chronic pancreatitis, and the risk of subsequent pancreatic cancer in diabetic patients: a population-based cohort study. J Gastroenterol (2012) 0.91
Insulin therapy and cancer. Diabetes Care (2013) 0.87
Insulin glargine use and short-term incidence of breast cancer - a four-year population-based observation. Acta Oncol (2012) 0.85
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. Exp Clin Endocrinol Diabetes (2008) 0.85
Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260. Diabetes (2010) 0.83
CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis. Curr Drug Saf (2013) 0.80
Risk of breast cancer in patients on long-acting insulin analogues in comparison with those on human insulin. Diabetologia (2012) 0.78
The impact of anti-diabetic drugs on colorectal cancer risk in a large cohort of women with diabetes. Libyan J Med (2012) 0.76
Screening and prostate-cancer mortality in a randomized European study. N Engl J Med (2009) 35.94
Prostate-cancer mortality at 11 years of follow-up. N Engl J Med (2012) 16.91
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (2009) 7.45
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Quality-of-life effects of prostate-specific antigen screening. N Engl J Med (2012) 7.21
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell (2012) 4.18
Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol (2012) 4.07
Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol (2009) 3.92
Completed suicide after a suicide attempt: a 37-year follow-up study. Am J Psychiatry (2004) 3.92
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry (2011) 3.71
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat (2011) 3.63
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol (2009) 3.03
Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J Natl Cancer Inst (2009) 2.90
Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med (2005) 2.84
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Balancing the harms and benefits of early detection of prostate cancer. Cancer (2010) 2.71
Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol (2010) 2.65
Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet (2003) 2.57
Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry (2006) 2.53
Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus. Arch Gen Psychiatry (2007) 2.45
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer (2011) 2.43
An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr (2007) 2.34
The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol (2007) 2.30
High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry (2004) 2.24
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
Residential radon and lung cancer--detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe. Scand J Work Environ Health (2006) 2.18
Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study. Lancet Oncol (2009) 2.17
Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland. Am J Obstet Gynecol (2008) 2.10
Diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter. Eur Urol (2007) 2.09
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst (2007) 2.08
Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr (2005) 2.07
State of the art in research into the risk of low dose radiation exposure--findings of the fourth MELODI workshop. J Radiol Prot (2013) 2.06
Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2007) 2.05
Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry (2004) 2.01
[Frequent drug interactions in general practice]. Ugeskr Laeger (2004) 2.01
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study. Breast Cancer Res Treat (2008) 1.96
Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study. Am J Med (2008) 1.96
Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ (2006) 1.91
Genetic determinants of height growth assessed longitudinally from infancy to adulthood in the northern Finland birth cohort 1966. PLoS Genet (2009) 1.89
Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer (2002) 1.89
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88
Risk of hip/femur fracture after stroke: a population-based case-control study. Stroke (2009) 1.88
Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet (2003) 1.87
Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke (2002) 1.86
Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med (2013) 1.86
HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study. J Bone Miner Res (2013) 1.84
Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry (2012) 1.84
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol (2002) 1.77
Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res (2009) 1.76
Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study. Urology (2002) 1.74
Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study. Stroke (2003) 1.74
The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study. Eur Urol (2011) 1.73
Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol (2014) 1.73
Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol (2009) 1.71
Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol (2008) 1.69
Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab (2007) 1.67
Silent research vessels are not quiet. J Acoust Soc Am (2007) 1.66
Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Arch Intern Med (2012) 1.66
Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res (2011) 1.65
Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer (2007) 1.64
Is nocturia equally common among men and women? A population based study in Finland. J Urol (2006) 1.64
Changes in mortality patterns following total hip or knee arthroplasty over the past two decades: a nationwide cohort study. Arthritis Rheumatol (2014) 1.61
A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry (2007) 1.61
Mortality from cancer and other causes in commercial airline crews: a joint analysis of cohorts from 10 countries. Occup Environ Med (2014) 1.61
Does the imprecise definition of overactive bladder serve commercial rather than patient interests? Eur Urol (2012) 1.59
Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet (2009) 1.58
Impact of pharmaceutical representative visits on GPs' drug preferences. Fam Pract (2009) 1.57
Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer (2004) 1.57
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56
Incidence of gliomas by anatomic location. Neuro Oncol (2007) 1.55
Age at onset and cognitive functioning in schizophrenia. Br J Psychiatry (2004) 1.54
Geographic variation and sociodemographic characteristics of psychotic disorders in Finland. Schizophr Res (2008) 1.54
The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database. J Hypertens (2009) 1.53
Smoking and bladder symptoms in women. Obstet Gynecol (2011) 1.52
Meta-analysis of mobile phone use and intracranial tumors. Scand J Work Environ Health (2006) 1.51
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens (2006) 1.48
Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. Am J Psychiatry (2005) 1.48
Selection bias due to differential participation in a case-control study of mobile phone use and brain tumors. Ann Epidemiol (2005) 1.48
Prognosis of non-specific musculoskeletal pain in preadolescents: a prospective 4-year follow-up study till adolescence. Pain (2004) 1.48